T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
+1.56%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$1.06T
AUM Growth
+$1.06T
Cap. Flow
-$84.1B
Cap. Flow %
-7.92%
Top 10 Hldgs %
26.1%
Holding
3,043
New
130
Increased
1,031
Reduced
1,522
Closed
110

Top Sells

1
GE icon
GE Aerospace
GE
$72.5B
2
V icon
Visa
V
$2.51B
3
INTU icon
Intuit
INTU
$2.08B
4
MTCH icon
Match Group
MTCH
$1.93B
5
CRM icon
Salesforce
CRM
$1.88B

Sector Composition

1 Technology 25.2%
2 Healthcare 16.24%
3 Consumer Discretionary 15.34%
4 Communication Services 13.81%
5 Financials 12.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HAACW
2901
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$36K ﹤0.01%
35,000
LPTH icon
2902
Lightpath Technologies
LPTH
$260M
$33K ﹤0.01%
15,300
NAT icon
2903
Nordic American Tanker
NAT
$671M
$33K ﹤0.01%
13,062
-400
-3% -$1.01K
RESN
2904
DELISTED
Resonant Inc.
RESN
$32K ﹤0.01%
13,400
-14,800
-52% -$35.3K
CRBP icon
2905
Corbus Pharmaceuticals
CRBP
$121M
$29K ﹤0.01%
28,410
ABEO icon
2906
Abeona Therapeutics
ABEO
$355M
$27K ﹤0.01%
+24,400
New +$27K
SONN icon
2907
Sonnet BioTherapeutics
SONN
$22.4M
$27K ﹤0.01%
45,100
URG
2908
Ur-Energy
URG
$569M
$27K ﹤0.01%
15,685
VYNE icon
2909
VYNE Therapeutics
VYNE
$8.18M
$27K ﹤0.01%
19,200
-20,850
-52% -$29.3K
RGLS
2910
DELISTED
Regulus Therapeutics
RGLS
$26K ﹤0.01%
+38,100
New +$26K
NMTR
2911
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
$26K ﹤0.01%
19,821
+1,500
+8% +$1.97K
EGIO
2912
DELISTED
Edgio, Inc. Common Stock
EGIO
$25K ﹤0.01%
+10,581
New +$25K
EMWP
2913
DELISTED
Eros Media World PLC
EMWP
$25K ﹤0.01%
27,140
-2,200
-7% -$2.03K
SVRA icon
2914
Savara
SVRA
$588M
$24K ﹤0.01%
17,260
EUCRW
2915
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$18K ﹤0.01%
22,697
TNXP icon
2916
Tonix Pharmaceuticals
TNXP
$252M
$17K ﹤0.01%
27,657
+1,400
+5% +$861
TRVN
2917
DELISTED
Trevena, Inc.
TRVN
$17K ﹤0.01%
13,712
TQQQ icon
2918
ProShares UltraPro QQQ
TQQQ
$26B
-6,200
Closed -$760K
VERV
2919
DELISTED
Verve Therapeutics
VERV
-685,000
Closed -$41.3M
WLFC icon
2920
Willis Lease Finance
WLFC
$1.11B
-5,295
Closed -$227K
WSBF icon
2921
Waterstone Financial
WSBF
$279M
-21,283
Closed -$418K
AFMD
2922
DELISTED
Affimed
AFMD
-45,045
Closed -$383K
AKYA
2923
DELISTED
Akoya BioSciences
AKYA
-500,644
Closed -$9.68M
ANVS icon
2924
Annovis Bio
ANVS
$45.4M
-3,000
Closed -$257K
ARDX icon
2925
Ardelyx
ARDX
$1.54B
-2,385,162
Closed -$18.1M